Back to top
more

Champions Oncology (CSBR)

(Delayed Data from NSDQ)

$4.85 USD

4.85
815

-0.07 (-1.42%)

Updated Apr 30, 2024 09:30 AM ET

After-Market: $4.93 +0.08 (1.65%) 7:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 251)

Industry: Medical - Drugs

Better trading starts here.

Zacks News

When Does Market Timing Actually Work? - February 05, 2020

Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?

Yes, You Can Time the Market. Find out How - August 26, 2019

Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?

Moving Average Crossover Alert: Champions Oncology

Champions Oncology, Inc. (CSBR) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

New Strong Sell Stocks for April 16th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

New Strong Sell Stocks for April 1st

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

New Strong Sell Stocks for March 27th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

New Strong Sell Stocks for March 25th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

Champions Oncology (CSBR) Q3 Earnings: What's in Store?

During Champions Oncology's (CSBR) third-quarter fiscal 2019 conference call, investor focus will be on the company's progress with its Ex Vivo platform and services.

Weakness Seen in Champions Oncology (CSBR) Estimates: Should You Stay Away?

Champions Oncology (CSBR) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Champions Oncology (CSBR) closed at $10.39, marking a +0.39% move from the previous day.

Champions Oncology (CSBR) Stock Sinks As Market Gains: What You Should Know

Champions Oncology (CSBR) closed the most recent trading day at $12.41, moving -1.43% from the previous trading session.

Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know

Champions Oncology (CSBR) closed at $13.43 in the latest trading session, marking a +1.13% move from the prior day.

Champions Oncology Sees Hammer Chart Pattern: Time to Buy?

Champions Oncology has been struggling lately, but the selling pressure may be coming to an end soon.

Has Champions Oncology (CSBR) Outpaced Other Medical Stocks This Year?

Is (CSBR) Outperforming Other Medical Stocks This Year?

Champions Oncology (CSBR) Gains As Market Dips: What You Should Know

Champions Oncology (CSBR) closed at $12.21 in the latest trading session, marking a +0.58% move from the prior day.